The modality of dialysis does not influence atheromatous vascular disease progression or cardiovascular outcomes in dialysis patients without previous cardiovascular disease

Autor/a

Borràs, Mercè

Pérez Fontán, Miguel

Martínez Alonso, Montserrat

Bajo, Auxiliadora

Betriu i Bars, M. Àngels

Valdivielso Revilla, José Manuel

Fernández i Giráldez, Elvira

Fecha de publicación

2018-01-09T11:33:57Z

2018-01-09T11:33:57Z

2017



Resumen

There is limited and inconclusive information regarding the influence of the modality of renal replacement therapy on the atherosclerotic burden of patients on dialysis. The aim of this study was to compare the prevalence of asymptomatic atheromatous carotid disease, as also its rate of progression and cardiovascular outcomes, in two matched populations of patients treated with hemodialysis (HD) and peritoneal dialysis (PD).


The NEFRONA study is funded by a research grant from AbbVie.

Tipo de documento

article
publishedVersion

Lengua

Inglés

Publicado por

Public Library of Science

Documentos relacionados

Reproducció del document publicat a https://doi.org/10.1371/journal.pone.0186921

Plos One, 2017, vol. 12, núm. 11, p. 1-16

http://hdl.handle.net/10459.1/65137

Derechos

cc-by (c) Borràs et al., 2017

http://creativecommons.org/licenses/by/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)